Etesevimab Uses, Dosage, Side Effects and more

Etesevimab (LY-CoV016, also known as JS016) is a fully human and recombinant monoclonal antibody that targets the SARS-CoV-2 surface spike protein receptor binding domain.

Attribute	Details
Trade Name	Etesevimab
Generic	Etesevimab
Etesevimab Other Names	Etesevimab
Weight	700mg/20ml
Type	Intravenous solution
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country	United States
Last Updated:	January 7, 2025 at 1:49 am

How Etesevimab works

Etesevimab aims to neutralize SARS-CoV-2 by specifically binding to the virus' surface spike protein receptor binding domain. This high affinity binding then prevents SARS-CoV-2 from binding to the ACE2 host cell surface receptor. Etesevimab is currently being investigated against COVID-19.

Innovators Monograph